Original Research
Utilization Challenges of Drugs for Multiple Sclerosis in a Medicaid Population
Drew A. Helmer, MD, MS, Nilanjana Dwibedi, BPharm, MBA, PhD, Mazhgan Rowneki, MPH, Chin-Lin Tseng, DrPH, Dennis Fried, PhD, Danielle Rose, PhD, Nisha Jani, MPH, PhD, Usha Sambamoorthi, PhD
Mental Health Conditions Constitute Significant Comorbidity: The Impact on Potentially Avoidable Hospital Admissions
Allison Petrilla, MPH, Elizabeth Marrett, MPH, Xian Shen, PhD, MS, BS, Winghan Jacqueline Kwong, PharmD, PhD, Edmund Pezalla, MD, MPH
Abuse-Deterrent Formulations of Prescription Opioids: A Missed Opportunity to Address the Current Opioid Crisis?
Improving Medication Use for Chronic Diseases by Reducing Costs, Increasing Patient Adherence
Outcomes-Based Contracts Gaining Traction: Innovative Therapies Will Require Innovative Payment Methods
Nihar R. Desai, MD, MPH, Pamala Reed, DrPH, MPH, Paula J. Alvarez, RPh, MBA, MPH, Jeanene Fogli, PhD, RD, Steven D. Woods, PharmD, Mary Kay Owens, RPh, CPh
The Impact of Quality Care on a Medicaid Population with Hyperkalemia
David Campbell, PharmD, MS, Marlo Blazer, PharmD, BCOP, Lisa M. Bloudek, PharmD, MS, John Brokars, MS, Dinara Makenbaeva, MD, MBA
The Challenges in Budgeting Potential Savings with the Launch of Generic Drugs
Michael C. Runken, PharmD, Joshua M. Noone, PhD, Christopher M. Blanchette, PhD, MBA, Emily Zacherle, MS, Reuben Howden, PhD
Shared Decision-Making and Payer Preferences: IVIG or SCIG Route of Administration?